Financial Performance Highlights - VONB increased by 14% to $2,838 million[11], driven by broad-based growth across 13 markets[49] - OPAT per share increased by 12%[11], reflecting higher earnings and ROE[41] - UFSG per share increased by 10% to $3,569 million[11] - Interim dividend per share increased by 10% to 49.00 HK cents[47] - $3.7 billion was returned to shareholders[13] Key Growth Drivers - AIA Hong Kong's VONB grew by 24% to $1,063 million[15], supported by agency and bancassurance channels[15] - AIA China's VONB reached $743 million in 1H25[17], with a VONB margin exceeding 65%[17] - ASEAN combined VONB increased by 20%[22], driven by traditional protection products[22] - Tata AIA Life's VONB increased by 38%[25], positioning it as a top 3 private life insurer in India[25] Strategic Initiatives - The company is deploying Gen AI at scale to accelerate growth across core platforms[38] - The company is focused on integrated healthcare strategy to make healthcare more accessible, affordable, and effective[35] - The company is building a differentiated and sustainable bancassurance model in China, focusing on HNW customers[104] Capital Management - The company maintains a strong shareholder capital ratio of 219% after returning $3.7 billion to shareholders[47, 82] - The company has a disciplined capital deployment strategy, with $22 billion returned since 2022[81] - The company targets a payout ratio of 75% of annual net free surplus generation[75]

Financial Performance - Revenue increased by 16.1% year-over-year to RMB 10 billion[7], with adjusted EBITDA up 20.6% to RMB 4.3 billion[7] and adjusted net profit up 11.6% to RMB 2.8 billion[7] - Gross profit margin improved by 360 basis points to 42.7%[7], with adjusted EBITDA margin at 43.3% and adjusted net profit margin at 28.5%[7] - Basic earnings per share (EPS) increased by 56.8% to RMB 0.58[7] Business Growth and Backlog - Integrated projects increased by 16.4% year-over-year to 864[8] with 86 new projects added in 1H 2025[9] - Commercial projects increased by 50% year-over-year to 24[9] - Total backlog reached US$20.3 billion[9, 16], including US$11.4 billion in service backlog[17] and US$4.2 billion within 3 years[17] Revenue Breakdown and Geography - Pre-IND revenue rose 35.2% year-over-year in 1H 2025[11] - Late-stage + CMO revenue increased by 24.9% year-over-year[12] - North America revenue grew 20.1% year-over-year, accounting for 60.5% of total revenue[21, 22] Capacity and Quality - The company completed 44 regulatory inspections with a 100% success rate[9, 66] - The company has 16 drug substance facilities and DP facilities with ~500,000L bioreactor capacity[51] Technology and Innovation - The company has enabled 50+ programs with potential milestone & sales royalty[13, 40] - The company is scaling out single-use technology to large batch sizes, with 339 batches across 5 manufacturing facilities[99] WBS and ESG - The company is improving gross margin through WBS initiatives[105] - The company is committed to sustainability and has received several ESG ratings and awards[108]

1 Disclaimer ◼These materials have been prepared by China State Construction International Holdings Ltd. ("CSCI" or the "Company") solely for information use during its presentation. It may not be reproduced or redistributed to any other person without the permissions from CSCI. By attending this presentation, you are agreeing to be bound by the foregoing restrictions. ◼It is not the intention to provide, and you may not rely on these materials as providing, a complete or comprehensive analysis of the compa ...

The Hong Kong and China Gas Company Limited (0003.HK) 2025 Interim Results 20 August 2025 1 The Hong Kong and China Gas | 2025 Interim Results 2025: Overall Operating Environment and Group Strategy Macro Environment Group Strategy Uncertainty in tariff policies affects industrial energy consumption Weak economy and slight decline in PMI affect exports "Launching the Construction of Zero-Carbon Parks" brings positive impacts to green energy The government boosts consumption through fiscal subsidies and consu ...

(Stock Code: 12) 8 Castle Road, Mid-Levels, HK (artist's impression) The Henderson Central, Hong Kong 2025 Interim Results Presentation 20th August 2025 Ballroom - Cloud 39, The Henderson, Central, HK 8 Castle Road, Mid-Levels, HK The Henderson Art Garden, Central, HK Disclaimer This presentation has been prepared by Henderson Land Development Company Limited (the "Company" or "HLD") solely for information purposes and does not constitute an offer, recommendation or invitation to subscribe for or purchase a ...

August 2025 Disclaimer 2 The information contained in this presentation is intended solely for your personal reference. Such information is subject to change without notice, its accuracy is not guaranteed and it may not contain all material information concerning Sunny Optical Technology (Group) Company Limited. The Company makes no representation regarding, and assumes no responsibility or liability for, the accuracy or completeness of, or any errors or omissions in, any information contained herein. In ad ...

Financial Performance - The company's revenue reached RMB 2.5 billion, a 19.5% year-over-year increase[13] - F-end and B-end corporate health management revenue totaled RMB 1.96 billion, representing a 30.2% year-over-year growth[13] - Net profit attributable to shareholders of the parent company increased by 136.8% year-over-year to RMB 130 million[13] - Adjusted net profit grew by 83.6% year-over-year to RMB 160 million[13] - Gross margin improved by 1.4 percentage points year-over-year to 33.6%[13] Business Growth and Service Expansion - Users entitled to family doctor service benefits increased by 150% year-over-year, reaching over 35 million[11,39] - The number of F-end paying users grew by 34.6% year-over-year to approximately 20 million[11,32] - B-end paying users increased by 39.2% year-over-year to over 3.6 million[11,35] - Users entitled to home-based senior care benefits increased by 83% year-over-year[11,40] - The company has over 3,500 paying corporate clients, a 37.2% year-over-year increase[11,35] AI and Technology Enablement - AI assistance enables doctors to handle approximately 4 million daily consultation requests[11,46] - AI-assisted inquiry and consultation accuracy rate is nearly 98%[11,46] - AI-driven cuts in family doctors' average service cost per customer by approximately 52% year-over-year[18,47]

Financial Performance Highlights - HKEX achieved record half-yearly revenue and other income of HK$14.1 billion, a 33% year-over-year increase[9] - Profit attributable to shareholders reached HK$8.5 billion in 1H 2025, up 39% year-over-year[11] - Core business revenue increased by 34% year-over-year to HK$13.0 billion in 1H 2025[16] - EBITDA increased by 43% year-over-year to HK$10.9 billion in 1H 2025[16] - Headline Average Daily Turnover (ADT) increased by 118% year-over-year[12] Business Segment Performance - Stock Connect revenue reached a record high of HK$1.813 billion, a 51% year-over-year increase[38] - Northbound Stock Connect ADT increased by 32% year-over-year[12] - Southbound Stock Connect ADT nearly tripled compared to 1H 2024[12] - Derivatives Average Daily Volume (ADV) reached a record half-yearly high of 1.7 million contracts, up 11% year-over-year[12] - LME ADV increased by 3% year-over-year[12] Strategic Initiatives and Market Dynamics - IPO funds raised reached HK$109.4 billion, more than 8 times that of 1H24[38]

Financial Performance - Yancoal reported a revenue of $2.68 billion, a 15% decrease compared to $3.138 billion in 1H 2024 [12, 76] - Operating EBITDA was $595 million, with a 23% margin [12] - Profit after tax reached $163 million, resulting in earnings per share of $0.12 [12] - The company holds $1.8 billion in cash with no interest-bearing loans [12] - An interim dividend of $82 million, or $0.0620 per share, was declared at a 50% payout ratio [12] Production and Operations - ROM coal production was 32.2Mt, a 16% increase from 1H 2024 [12, 28] - Saleable coal production reached 24.8Mt, a 15% increase from 1H 2024 [12, 22] - Attributable saleable coal production was 18.9Mt, an 11% increase compared to 1H 2024 [12, 33] - Cash operating costs decreased by 8% to $93/tonne compared to 1H 2024 [12, 37] Safety - The 12-month rolling Total Recordable Injury Frequency Rate (TRIFR) was 6.32, an improvement from 6.73 at the end of 2024, and remains below the industry weighted average of 7.93 [12, 17]

Financial Performance - Group revenue reached RMB 116.0 billion, a 30.5% year-over-year increase[11] - Gross profit margin was 22.5%, up 1.8 percentage points year-over-year[11] - Adjusted net profit reached RMB 10.8 billion, a 75.4% year-over-year increase[11] - Smart EV, AI and other new initiatives revenue reached RMB 21.3 billion, a 233.9% year-over-year increase[11] Smartphone Business - Global smartphone market share ranked top 3 with 14.7%[16] - Mainland China smartphone market share increased 1.0 percentage point year-over-year to 15.3%[16] - Premium smartphone as a percentage of total smartphone units sold in Mainland China increased 5.5 percentage points year-over-year to 27.6%[16] - Global smartphone shipments reached 42.4 million units[38] IoT and Lifestyle Products - IoT and lifestyle products revenue reached RMB 38.7 billion, up 44.7% year-over-year[79] - Smart large home appliances revenue increased 66.2% year-over-year[16] - Global tablet shipments increased 42.3% year-over-year[16] Smart EV and AI Initiatives - Smart EV sales revenue reached RMB 20.6 billion, up 230.3% year-over-year[84] - Xiaomi EV quarterly delivery reached 81,302 vehicles[16] - Locked-in orders for Xiaomi YU7 series reached 240,000 units in 18 hours[16]